To Demonstrate Equivalence of Pharmacokinetics and Noninferiority of Efficacy for CT-P10 in Comparison With Rituxan

NCT02162771 · clinicaltrials.gov ↗

PHASE3

Phase

COMPLETED

Status

140

Enrollment

INDUSTRY

Sponsor class

Conditions

Lymphoma, Follicular

Interventions

BIOLOGICAL: Rituxan
BIOLOGICAL: CT-P10
DRUG: Cyclophosphamide
DRUG: Vincristine
DRUG: Prednisone

Sponsor

Celltrion